Advances in viral hepatitis: 50 years of Australian gastroenterology.
Viral hepatitis classification, treatments and pathogenesis has been increasingly defined over the past 50 years. Australian researchers have made significant contributions in the areas of viral hepatitis A vaccine development, treatment outcomes for chronic hepatitis B and C, the role of liver transplantation and the pathogenesis of injury and disease progression. This review outlines some of these contributions.
McCaughan
Geoff
G
AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Missenden Road, Camperdown NSW 2050, Australia. g.mccaughan@centenary.usyd.edu.au
D000818:Animals; D000998:Antiviral Agents / Q000266:history* / Q000627:therapeutic use; D001315:Australia; D035843:Biomedical Research / Q000266:history*; D018450:Disease Progression; D005762:Gastroenterology / Q000266:history*; D006506:Hepatitis A / Q000266:history; D022362:Hepatitis A Vaccines / Q000266:history; D006509:Hepatitis B / Q000266:history; D017325:Hepatitis B Vaccines / Q000266:history; D006526:Hepatitis C / Q000266:history; D006525:Hepatitis, Viral, Human / Q000175:diagnosis / Q000266:history* / Q000628:therapy; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D016031:Liver Transplantation / Q000266:history*; D014761:Viral Hepatitis Vaccines / Q000266:history*
D000998:Antiviral Agents; D022362:Hepatitis A Vaccines; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines